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A Cochrane review1 has concluded that there is no good
randomised clinical trial evidence on which to base
treatment guidelines for patients with very late-onset
schizophrenia-like psychosis (VLOSLP),2 yet open treatment
with atypical antipsychotics has been associated with
improvements in symptoms at least as good as those seen
in younger patients with schizophrenia or patients with
early-onset schizophrenia who have grown old,3-5 and
antipsychotic treatment is the cornerstone of care pathways.
Little is known about how many patients seen within
specialist mental health services are engaged by those
services and given antipsychotic treatment. To address this,
we conducted a retrospective electronic patient record search.
Method
Participants
We used the Clinical Record Interactive Search (CRIS)
system, developed within the National Institute for Health
Research (NIHR) Mental Health Biomedical Research
Centre, South London and Maudsley NHS Foundation
Trust, to extract the records of all patients aged 60 years
and above with a diagnosis of schizophrenia, schizotypal
and/or delusional disorders (ICD-10 F20-F29)6 in contact
with services between 1 January 2007 and 21 August 2014.
All identiﬁed patients’ notes were reviewed and those who
scored 24 or less on the standardised mini-mental state
examination7 or had a concurrent diagnosis of an organic
mental disorder (ICD-10 F00-F09)6 were excluded. Other
exclusion criteria included any evidence that psychosis
onset had been before the age of 60, insufﬁcient recorded
information to conﬁrm diagnosis and less than 1 year of
follow-up completed at time of CRIS search.
Events
The ﬁrst face-to-face contact of mental health services with
a patient was regarded as the start point of each service
episode. Records were reviewed at 3 months to assess initial
engagement with services. If a patient was discharged before
3 months, the last documented episode was used as an
alternative. Two further engagement points, at 6 months
and 12 months, were also examined. The length of each
episode was also extracted and the level of engagement at
the point of discharge from services was assessed.
Ethics approval for CRIS was given by the National
Research Ethics Service Oxford REC C.
Results
Search of the CRIS system initially identiﬁed 635 patients.
Following inspection of the individual records, patients
were excluded because of incorrect coding (n = 45), cognitive
impairment (n = 216), onset of psychosis before age 60 years
(n = 150), insufﬁcient information to conﬁrm diagnosis
(n = 32) or in contact with services for less than 12 months
preceding the search date (n = 61). Of the remaining 131
patients, 84 (64.1%) were female, 40 (30.5%) were White
British, and 35 (26.7%) were living with a partner or family
member. The extent of engagement with services and
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Aims and method Electronic patient records were used to investigate the level of
engagement and treatment that patients with very late-onset schizophrenia-like
psychosis (VLOSLP) had with mental health services.
Results Of 131 patients assessed and diagnosed, 63 (48%) were taking
antipsychotic treatment at 3 months, 46 (35%) at 6 months and 36 (27%) at 12
months. At discharge from mental health services, 54% of patients had failed to
engage with services or became lost to follow-up, 18% had engaged with services but
were not taking antipsychotic medication and only 28% were taking treatment.
Clinical implications Results showed that less than half of the patients with VLOSLP
were commenced on antipsychotic treatment and less than a third remained on
treatment at 1 year or at point of discharge. This highlights the need for services to
consider being more assertive in taking potentially effective treatment to this patient
group.
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antipsychotic treatment at 3, 6 and 12 months is shown in
Fig. 1. At the point of discharge from specialist services back
to primary care, 65 patients (54%) had been lost to follow-up
or had not engaged with specialist services, 22 (18%) had
engaged with services but were not receiving antipsychotic
treatment, and 33 (28%) were taking antipsychotic treatment.
The rest were still receiving active specialist service follow-up.
Twenty-six (19.8%) patients were treated compulsorily under a
section of theMentalHealth Act 1983, and neithermale gender
(odds ratio (OR) 1.15: 95% CI 0.47-2.80) nor membership of a
Black or minority ethnic group (OR= 1.25: 95% CI 0.52-3.02)
signiﬁcantly inﬂuenced Mental Health Act use.
Discussion
The diagnostic concept of VLOSLP emerged from an
international consensus meeting held to advance research
on a patient group with ﬁrst onset of delusions and/or
hallucinations after the age of 60 years, in the absence of
affective disorder or demonstrable brain disease such as
dementia.2 The illness is viewed as a functional psychosis
with symptoms that will respond to antipsychotic drugs.2-5
Our data show that less than half of patients with VLOSLP
were commenced on antipsychotic treatment and less than
a third remained on treatment at 1 year or at the point of
discharge from services. This is a surprising, even
disappointing, result. An important barrier to acceptance
of antipsychotic treatment by patients with VLOSLP is the
low level of insight into presence of mental health
difﬁculties or need for treatment.8 Although treatment-
related decision-making capacity has not been speciﬁcally
investigated in VLOSLP, studies of middle-aged and older
patients with schizophrenia have suggested that cognitive
test scores, rather than psychopathology ratings, associate
most strongly with the understanding and reasoning
components of capacity.9 Patients with VLOSLP do not,
however, have demonstrably abnormal brain imaging10 and
do not inevitably progress to develop dementia,11,12 so
cognitive impairment is unlikely to explain their inability to
evaluate their illness or the need for treatment. Reluctance
by clinicians to use mental health law to deliver compulsory
treatment when patients will not accept the case for
antipsychotic treatment is indicated by the small percen-
tage of cases where this happened. Although there are
limited studies to compare this with, it is in keeping with
the lower rates of patients on longer-term detention within
the above-65 population.13 This may reﬂect a view that
elderly patients with psychosis are somehow less ‘risky’ and
that a failure to enforce treatment is therefore justiﬁable. In
fact, untreated symptoms of VLOSLP are frightening and
disabling, lead patients to place themselves at signiﬁcant
risk and damage relationships with family and neighbours.
Comparably low levels of psychosis treatment in younger
people would be completely unacceptable and specialist
mental health services for older people should actively
consider whether they should be more assertive in taking
potentially effective treatment to this vulnerable patient group.
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Fig. 1 Service and antipsychotic treatment engagement over 12
months.
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